Erik Tambuyzer to speak at 2019 Innovation Bootcamp in Rare Diseases

Erik Tambuyzer to speak at 2019 Innovation Bootcamp in Rare Diseases – Leuven, Belgium November 4-5

September 6, 2019

Erik Tambuyzer, Chairperson for BioPontis Alliance for Rare Diseases, is scheduled to appear at the 2019 Innovation Bootcamp in Rare Diseases being held in Leuven, Belgium this 4-5 November. He will speak on ‘Opportunities and challenges in orphan drug development: policies and technology platforms.’ Review the program announcement for the event schedule and speaker list. Registration is open for attendance at this distinct event offering insights to innovation in diagnostics, therapies and the economic environment of rare disease.


About BioPontis Alliance for Rare Diseases

BioPontis Alliance for Rare Diseases is a 501c(3) public charity in the US (North Carolina) and a foundation of public utility (fup/son) in Belgium (Brussels). Managed by an international Board and executive team, BioPontis partners with patient organizations and clinical researchers to bridge the gap between promising science and new medicines. BioPontis Alliance for Rare Diseases is being established as a global non-profit, inviting corporate, private and foundation philanthropic support. More information, including how contributions to support our programs and mission can be made, at http://biopontisalliance.org.

Contacts:

David Spencer, PhD – CSO
BioPontis Alliance for Rare Diseases
+1.919.624.0841 (Raleigh, USA)
dspencer@biopontisalliance.org

Erik Tambuyzer, PhD – Chairperson
BioPontis Alliance for Rare Diseases
+32 475 61 57 11 (Brussels, Belgium)
Erik.Tambuyzer@biopontisalliance.org